Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 25,746 followers.

We've detected a paper from Frontiers in Oncology that cites a retracted paper post-retraction. Citing paper: https://t.co/dCrFauW2YE Retracted paper: https://t.co/ITQyEniDDA

06 Apr 2023

Reply Repost Favourite

Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer https://t.co/Tvz5DXeNbH https://t.co/T157M7ZzYi

06 Feb 2023

Reply Repost Favourite

New research: Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer: Introduction Tumorigenesis in breast cancers usually accompanied by the dysregulation of transcription factors (TFs). Abnormal… https://t.co/F4R7vr

06 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.